KemPharm

<!-- Name:DistributionId Value:8779313 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

<!-- Name:DistributionId Value:8756028 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

<!-- Name:DistributionId Value:8755087 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:4500 -->…

Phase 2 clinical trial investigating KP1077 in patients with IH expected to initiate prior to year-end 2022